Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The impact of low-risk genetic variants in self-limited epilepsy with centrotemporal spikes aka Rolandic epilepsy

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Fasting unmasks differential fat and muscle transcriptional regulation of metabolic gene sets in low versus normal birth weight men

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fish-oil supplementation in pregnancy, child metabolomics and asthma risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pathogenesis and biomarkers for necrotizing enterocolitis: Getting any closer?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The renal extraction and the natriuretic action of GLP-1 in humans depend on interaction with the GLP-1 receptor

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Counterregulatory responses to postprandial hypoglycemia after Roux-en-Y gastric bypass

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fractionated free fatty acids and their relation to diabetes status after Roux-en-Y gastric bypass: A cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Roux-en-Y Gastric bypass surgery (RYGB) is emerging as a powerful tool for treatment of obesity and may also cause remission of type 2 diabetes. However, the molecular mechanism of RYGB leading to diabetes remission independent of weight loss remains elusive. In this study, we profiled plasma metabolites and proteins of 10 normal glucose-tolerant obese (NO) and 9 diabetic obese (DO) patients before and 1-week, 3-months, 1-year after RYGB. 146 proteins and 128 metabolites from both NO and DO groups at all four stages were selected for further analysis. By analyzing a set of bi-molecular associations among the corresponding network of the subjects with our newly developed computational method, we defined the represented physiological states (called the edge-states that reflect the interactions among the bio-molecules), and the related molecular networks of NO and DO patients, respectively. The principal component analyses (PCA) revealed that the edge states of the post-RYGB NO subjects were significantly different from those of the post-RYGB DO patients. Particularly, the time-dependent changes of the molecular hub-networks differed between DO and NO groups after RYGB. In conclusion, by developing molecular network-based systems signatures, we for the first time reveal that RYGB generates a unique path for diabetes remission independent of weight loss.

Original languageEnglish
JournalEBioMedicine
Pages (from-to)234-240
DOIs
Publication statusPublished - Feb 2018
Externally publishedYes

    Research areas

  • Journal Article

ID: 52684918